Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Biogen Inc.
Short
Jun 1, 2021
BIIB Alzheimer's drug pending approval by the FDA
1
Grab this chart
Grab this chart
bizjournals.com/boston/news/2021/05/31/biogen-aducanumab-alzheimers-drug-fda-deadline.html
Sticky_green
Follow
biotech
Trend Analysis
Sticky_green
Follow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.